• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Janssen’s Biologics Rybrevant Faspro Receives Approval in US

    FDA

    Janssen’s Biologics Stelara Receives Suppl Approval in US

    FDA

    Johnson & Johnson`s Balversa (Erdafitinib) Receives Approval in Europe

    EMA

    Janssen`s Biologic Tecvayli (teclistamab) Receives Approval in the U.S.

    FDA

    Janssen`s Biologic Talvey (talquetamab) Receives Approval in the U.S.

    FDA

    Janssen Biotech`s Biologic Darzalex (Daratumumab) Receives Approval in the U.S.

    FDA

    Janssen`s Biologic Darzalex Faspro gets Approval in the U.S.

    FDA

    Janssen-Cilag NV`s Erleada (Apalutamide) Receives Approval in Europe

    EMA

    Janssen`s Invega Trinza (3- Month Paliperidone Palmitate) Approved in US For Schizophrenia

    JANSSEN

    Janssen`s Generic Paliperidone Janssen (Paliperidone 25 mg, 50 mg, 75 mg, 100 mg and 150 mg) Approved in Europe for Schizophrenia

    EMA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.